Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab

被引：2
|
作者：
Hui, Jessica W. [1 ]
Banks, Mindy [2 ]
Nadasdy, Tibor [3 ]
Rovin, Brad H. [4 ]
Abbott, Jordan K. [1 ]
机构：
[1] Natl Jewish Hlth, Dept Pediat, Immunodeficiency Diag & Treatment Program, Denver, CO USA
[2] Rocky Mt Hosp Children, Dept Pediat, Nephrol Div, Denver, CO USA
[3] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA
[4] Ohio State Univ, Dept Med, Div Nephrol, Columbus, OH 43210 USA
来源：
KIDNEY INTERNATIONAL REPORTS | 2020年 / 5卷 / 06期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.ekir.2020.03.022
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：951 / 954
页数：4
相关论文
共 50 条
  • [21] Treating C3 glomerulopathy with eculizumab
    Thomas Welte
    Frederic Arnold
    Julia Kappes
    Maximilian Seidl
    Karsten Häffner
    Carsten Bergmann
    Gerd Walz
    Elke Neumann-Haefelin
    BMC Nephrology, 19
  • [22] Successful therapeutic use of rituximab in refractory membranous glomerulonephritis
    Cobo, M.
    Hernandez, D.
    Rodriguez, C.
    Perez-Tamajon, L.
    CLINICAL NEPHROLOGY, 2006, 66 (01) : 54 - 57
  • [23] Two Different Presentation of C3 Glomerulonephritis Treated with Eculizumab: Two Cases and Brief Overview
    Ozturk, Yasin
    Ozer, Hakan
    Baloglu, Ismail
    Turkmen, Kultigin
    TURKISH JOURNAL OF NEPHROLOGY, 2023, 32 (01): : 86 - 89
  • [24] Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy
    Levart, Tanja Kersnik
    Ferluga, Dusan
    Vizjak, Alenka
    Mraz, Jerica
    Kojc, Nika
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [25] C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature
    Fernandez-Ruiz, Ruth
    Blank, Rebecca B.
    Wu, Ming
    Belmont, H. Michael
    LUPUS, 2021, 30 (10) : 1671 - 1678
  • [26] Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy
    Tanja Kersnik Levart
    Dušan Ferluga
    Alenka Vizjak
    Jerica Mraz
    Nika Kojc
    Diagnostic Pathology, 11
  • [27] Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
    Julien Zuber
    Fadi Fakhouri
    Lubka T. Roumenina
    Chantal Loirat
    Véronique Frémeaux-Bacchi
    Nature Reviews Nephrology, 2012, 8 : 643 - 657
  • [28] Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
    Zuber, Julien
    Fakhouri, Fadi
    Roumenina, Lubka T.
    Loirat, Chantal
    Fremeaux-Bacchi, Veronique
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (11) : 643 - 657
  • [29] Successful Treatment of Posttransplant Recurrent Complement C3 Glomerulopathy with Eculizumab
    Sahin, Hatice
    Oguz, Ebru Gok
    Akoglu, Hadim
    Atilgan, Gokhan
    Okyay, Gulay Ulusal
    Gursoy, Guner Karaveli
    Teymur, Tugba Kip
    Ertoy, Dilek
    Canbakan, Basol
    Ayli, Mehmet Deniz
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (05) : 315 - 318
  • [30] ACQUIRED C3 GLOMERULONEPHRITIS PRESUMABLY SECONDARY TO RHEUMATOID ARTHRITIS SUCCESSFULLY TREATED WITH RITUXIMAB
    Hussain, Faizul
    Lamarche, Jorge
    Peguero, Alfredo
    Courville, Craig
    Taha, Mohamed
    Antar-Shultz, Marina
    Haley, James A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (04) : A53 - A53
12345